H.R. 2223 · 110th Congress
To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney…
Full title
To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 110th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
PorterSponsor5 cosponsors · 1 D, 4 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Requires the Director of the Office of National Drug Control Policy to study and report to Congress on prescription drug disposal programs in which individuals return unused prescription drugs to pharmacies or other locations, focusing on certain issues including: (1) best practices of such programs; (2) affects of such programs on pharmacies; and (3)…
What it does: CRS summary · Introduced in House · May 8, 2007
Requires the Director of the Office of National Drug Control Policy to study and report to Congress on prescription drug disposal programs in which individuals return unused prescription drugs to pharmacies or other locations, focusing on certain issues including: (1) best practices of such programs; (2) affects of such programs on pharmacies; and (3) training and infrastructure needed to ensure the success of such programs.
Requires the Administrator of the Environmental Protection Agency (EPA) to conduct a study identifying the environmental impacts of current prescription drug disposal programs and methods.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.
Latest action (May 8, 2007): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: May 8, 2007
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.